Candida Polyarthritis in a Renal Transplant Patient.
- Author:
Je Hoon PARK
1
;
Kwang Woong LEE
;
Seong Eun CHON
;
Sung Joo KIM
;
Suk Koo LEE
;
Woo Sung HUH
;
Ha Yeong OH
;
Yong Il KIM
;
Byung Boong LEE
;
Jae Won JOH
Author Information
1. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jwjoh@smc.smasung.co.kr
- Publication Type:Case Report
- Keywords:
Candida albicans;
Arthrits;
Kidney transplantation
- MeSH:
Amphotericin B;
Anti-Bacterial Agents;
Arthritis*;
Arthritis, Infectious;
Candida albicans;
Candida*;
Candidiasis;
Catheters;
Causality;
Humans;
Kidney Transplantation;
Mortality
- From:The Journal of the Korean Society for Transplantation
2001;15(2):237-239
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Candidal infection has been known to cause significant morbidity and mortality in renal transplant patients. Type of immunosuppressive regimens, prolonged antibiotics therapy, metabolic derangement such as diabetes and corticosteroid use, the long-term use of indwelling urinary and intravenous catheters are important predisposing factors in the development of candidal infection. Septic arthritis caused by Candida species is relatively uncommon, occurring most frequently as a complication of disseminated candidiasis. Although several drugs are available for the treatment of Candida arthritis, intravenous amphotericin B therapy has been shown to most consistently result in successful treatment. We report herein successful outcome of treatment with amphotericin B for septic arthritis due to C. albicans after a successful second renal transplant.
